Company: SYRA
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001641172-25-009279
Chunk: 1

Company: Syra Health Corp
Filing Date: 2025-05-08
Form: 10-Q
Item: Item 1
Chunk 1
---
5 and December 31, 2024, respectively 
     11,339  
     8,979 
  
    Convertible class B common stock, $0.001 par value, 5,000,000 shares authorized, 600,000 and 833,334 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively 
     600  
     833 
  
    Common stock, value 
     600  
     833 

    Additional paid-in capital 
     11,741,155  
     11,692,952 
  
    Accumulated deficit 
     (9,296,458) 
     (8,824,193)
  
    Total stockholders’ equity (deficit) 
     2,456,636  
     2,878,571 

    Total liabilities and stockholders’ equity (deficit) 
    $3,722,550  
    $3,679,332 

See accompanying notes to condensed unaudited
financial statements.

F-1

SYRA HEALTH CORP.

CONDENSED STATEMENTS OF
OPERATIONS

(Unaudited)

    For the Three Months Ended 

    March 31, 

    2025  
    2024 

    Net revenues 
    $1,857,774  
    $1,752,340 
  
    Cost of services 
     1,268,618  
     1,452,561 
  
    Gross profit 
     589,156  
     299,779 

    Operating expenses: 

    Salaries and benefits 
     507,207  
     736,303 
  
    Professional services 
     224,026  
     194,580 
  
    Research and development expenses 
     37,173  
     277,548 
  
    Selling, general and administrative expenses 
     287,287  
     522,757 
  
    Depreciation 
     6,797  
     12,545 
  
    Total operating expenses 
     1,062,490  
     1,743,733 

    Operating loss 
     (473,334) 
     (1,443,954)

    Other income (expense): 

    Interest income 
     4,298